Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel 2,3-dioxygenase inhibitor disclosed by Incyte for cancer immunotherapy

Dec. 1, 2009

Preclinical characterization of RP-1040 disclosed at 2009 AACR-NCI-EORTC meeting

Nov. 30, 2009

GW-876008 improves stress-induced rectal hypersensitivity in patients with IBS

Nov. 30, 2009

ICOVIR-17 adenovirus displays enhanced intratumoral distribution and activity in vivo

Nov. 30, 2009

Antimalaria vaccine elicits functional antibodies in phase I trial in malaria-naive subjects

Nov. 30, 2009

Cytokinetics discloses preclinical data on novel smooth muscle myosin inhibitors

Nov. 30, 2009

Aflibercept shows promise in phase II trial in metastatic melanoma patients

Nov. 27, 2009

Promising phase II data on AZD-0837 support further evaluation in AF patients

Nov. 27, 2009

Ondansetron confers no significant improvement in emesis in children with acute gastroenteritis

Nov. 27, 2009

Once-daily mesalazine is as effective as twice-daily dosing in UC remission maintenance

Nov. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...